Respiratory Infections and Inflammations with MCC
Major Diagnostic Category 04·Grouped by diagnosis·FY 2027
MS-DRG 177 is a Medical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 04 (MDC 04) with a Major Complication or Comorbidity (MCC). It maps to 64 ICD-10-CM diagnosis codes. For FY 2027 it carries a relative weight of 1.6092 with a geometric mean length of stay of 4.5 days and an arithmetic mean of 5.8 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 1.6092 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 4.5 days (used for transfer payments)
- Average stay:
- 5.8 days (arithmetic mean)
- Post-acute transfer policy:
- Yes (early transfers can be paid less)
Same condition, other severity levels
CMS splits one condition into separate DRGs by how sick the patient is. With MCC pays more than with CC, which pays more than without CC/MCC.
Diagnosis codes (64)
As the principal diagnosis, these ICD-10-CM codes can group to DRG 177. 100% of the codes listed are billable.
- A02.22Salmonella pneumonia
- A06.5Amebic lung abscess
- A15.0Tuberculosis of lung
- A15.4Tuberculosis of intrathoracic lymph nodes
- A15.5Tuberculosis of larynx, trachea and bronchus
- A15.6Tuberculous pleurisy
- A15.7Primary respiratory tuberculosis
- A15.8Other respiratory tuberculosis
- A15.9Respiratory tuberculosis unspecified
- A20.2Pneumonic plague
- A21.2Pulmonary tularemia
- A22.1Pulmonary anthrax
- A31.0Pulmonary mycobacterial infection
- A42.0Pulmonary actinomycosis
- A43.0Pulmonary nocardiosis
- A48.1Legionnaires' disease
- A52.72Syphilis of lung and bronchus
- B01.2Varicella pneumonia
- B05.2Measles complicated by pneumonia
- B25.0Cytomegaloviral pneumonitis
- B37.1Pulmonary candidiasis
- B38.0Acute pulmonary coccidioidomycosis
- B38.1Chronic pulmonary coccidioidomycosis
- B38.2Pulmonary coccidioidomycosis, unspecified
- B39.0Acute pulmonary histoplasmosis capsulati
- B39.1Chronic pulmonary histoplasmosis capsulati
- B39.2Pulmonary histoplasmosis capsulati, unspecified
- B44.0Invasive pulmonary aspergillosis
- B58.3Pulmonary toxoplasmosis
- B59Pneumocystosis
- B66.4Paragonimiasis
- B67.1Echinococcus granulosus infection of lung
- E84.0Cystic fibrosis with pulmonary manifestations
- J10.00Influenza due to other identified influenza virus with unspecified type of pneumonia
- J10.01Influenza due to other identified influenza virus with the same other identified influenza virus pneumonia
- J10.08Influenza due to other identified influenza virus with other specified pneumonia
- J11.00Influenza due to unidentified influenza virus with unspecified type of pneumonia
- J11.08Influenza due to unidentified influenza virus with specified pneumonia
- J15.0Pneumonia due to Klebsiella pneumoniae
- J15.1Pneumonia due to Pseudomonas
- J15.20Pneumonia due to staphylococcus, unspecified
- J15.211Pneumonia due to Methicillin susceptible Staphylococcus aureus
- J15.212Pneumonia due to Methicillin resistant Staphylococcus aureus
- J15.29Pneumonia due to other staphylococcus
- J15.5Pneumonia due to Escherichia coli
- J15.61Pneumonia due to Acinetobacter baumannii
- J15.69Pneumonia due to other Gram-negative bacteria
- J15.8Pneumonia due to other specified bacteria
- J17Pneumonia in diseases classified elsewhere
- J4BPulmonary mycetoma
- J69.0Pneumonitis due to inhalation of food and vomit
- J69.1Pneumonitis due to inhalation of oils and essences
- J69.8Pneumonitis due to inhalation of other solids and liquids
- J85.0Gangrene and necrosis of lung
- J85.1Abscess of lung with pneumonia
- J85.2Abscess of lung without pneumonia
- J85.3Abscess of mediastinum
- J86.0Pyothorax with fistula
- J86.9Pyothorax without fistula
- J98.51Mediastinitis
- J98.59Other diseases of mediastinum, not elsewhere classified
- R76.11Nonspecific reaction to tuberculin skin test without active tuberculosis
- R76.12Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis
- U07.1COVID-19
